Determining the minimum clinically important differences for outcomes in the DOMINO trial
Robert Howard(University College London), Richard Gray(Barnsley Hospital NHS Foundation Trust), Martín Knapp(London School of Economics and Political Science), John T. O’Brien(North Tyneside General Hospital), Patrick Phillips(Unknown), Robin Jacoby(University of Oxford), Robert Barber(University of North Texas), Alistair Burns(University of Manchester), Clive Ballard(University of Exeter), Craig Ritchie(Western General Hospital), Sube Banerjee(University of Nottingham), James Lindesay(University of Leicester), Tom Dening(University of Nottingham), Bart Sheehan(University of Warwick), Roy Jones(Royal United Hospital), Richard G. Brown(Imperial College London), Peter Bentham(Queen Elizabeth Hospital Birmingham), Mary Griffin(Avon and Wiltshire Mental Health Partnership NHS Trust), Peter Passmore(Queen's University Belfast), Ashley Baldwin(Whiston Hospital), Clive Holmes(University of Eastern Finland), David M. Findlay(The University of Adelaide), Ajay Macharouthu(Crichton Royal Hospital), Tony Johnson(University of Liverpool), Jessica Adams, Ian G. McKeith(Newcastle Hospitals - Campus for Ageing and Vitality), Alan Hughes(Inverclyde Royal Hospital), Rob Jones(University of Nottingham)
Cited by 177
Related Papers
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Cost of disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|1.7k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k